Answers are grounded in this paper and cite their sources.
The aim of the study is to compare treatment outcomes of the patients with federation of gynecology and obstetrics stages III and IV ovarian carcinomas, who underwent interval debulking surgery after neoadjuvant chemotherapy (NACT), and patients who underwent adjuvant chemotherapy after primary debulking surgery (PDS). METHODSPatients from four centers (n=183) were retrospectively evaluated.Of the patients, 91 (50%) were in the PDS group and 92 (50%) in the NACT group. RESULTSIn the NACT group patients have advanced age, poor performance status, high levels of CA125, and advanced disease stage compared with the PDS group (p<0.050).
No takes yet. Share an insight, caveat, or question.
Mukaddes Yılmaz (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: